
UB535
ProductKetorolac tromethamine Nasal Spray
Strength1.7g, 8 sprays
IndicationsPain; Postoperative pain; Swelling
TherapeuticsAnesthesiology
GMPUS - FDA
RegistrationUnited States
ModalitiesSmall Molecule
Exclusive Summary
- The product holds US FDA GMP certification and US registration, demonstrating high quality and regulatory compliance for global market entry.
- Ketorolac tromethamine nasal spray offers rapid, non-oral pain relief, addressing significant needs in acute pain management like post-operative pain and migraines.
- This nasal spray formulation presents a unique advantage over oral analgesics and original brands, positioning it favorably in the global pain management market.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →